| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1996PNAS...93..845V |
| P356 | DOI | 10.1073/PNAS.93.2.845 |
| P932 | PMC publication ID | 40145 |
| P698 | PubMed publication ID | 8570646 |
| P5875 | ResearchGate publication ID | 14629173 |
| P50 | author | David M. Ornitz | Q37386214 |
| Andrew B Herr | Q50282143 | ||
| P2093 | author name string | R Sasisekharan | |
| G Waksman | |||
| R Langer | |||
| G Venkataraman | |||
| C L Cooney | |||
| V Sasisekharan | |||
| P2860 | cites work | N.m.r. and molecular-modelling studies of the solution conformation of heparin | Q24528140 |
| Three-dimensional structure of human basic fibroblast growth factor, a structural homolog of interleukin 1 beta | Q24563285 | ||
| Three-dimensional structure of human basic fibroblast growth factor | Q24563295 | ||
| Crystal structure of basic fibroblast growth factor at 1.6 A resolution | Q27647318 | ||
| New protein fold revealed by a 2.3-A resolution crystal structure of nerve growth factor | Q27656280 | ||
| Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor | Q27729397 | ||
| Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans | Q28213234 | ||
| Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
| Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation | Q28296150 | ||
| Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor | Q29616189 | ||
| Refinement of the structure of human basic fibroblast growth factor at 1.6 Å resolution and analysis of presumed heparin binding sites by selenate substitution | Q30194894 | ||
| Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis | Q30419847 | ||
| Receptor- and heparin-binding domains of basic fibroblast growth factor | Q33564620 | ||
| Structure and mechanism of copper, zinc superoxide dismutase | Q34255150 | ||
| Heparinase inhibits neovascularization | Q35056165 | ||
| The FGF family of growth factors and oncogenes | Q35335377 | ||
| Complexity of FGF receptors: genetic basis for structural diversity and functional specificity | Q35595596 | ||
| A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane | Q35818217 | ||
| A dual receptor system is required for basic fibroblast growth factor activity | Q36428185 | ||
| Extracellular matrix-resident basic fibroblast growth factor: Implication for the control of angiogenesis | Q36657969 | ||
| The heparin-binding (fibroblast) growth factor family of proteins | Q38286731 | ||
| FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. | Q38296447 | ||
| Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor | Q38314305 | ||
| Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4 | Q38314349 | ||
| Preparation of affinity-fractionated, heparin-derived oligosaccharides and their effects on selected biological activities mediated by basic fibroblast growth factor. | Q38321029 | ||
| Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells | Q38331586 | ||
| Dimerization of cell surface receptors in signal transduction | Q40579106 | ||
| Structural and functional basis for hormone binding and receptor oligomerization | Q40668266 | ||
| The ins and outs of fibroblast growth factors | Q40694270 | ||
| The coordinated regulation of heparan sulfate, syndecans and cell behavior | Q40780342 | ||
| Heparin increases the affinity of basic fibroblast growth factor for its receptor but is not required for binding. | Q41487982 | ||
| Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis | Q42476789 | ||
| Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperactivity | Q42816414 | ||
| Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation | Q54246457 | ||
| Surface, subunit interfaces and interior of oligomeric proteins | Q68014868 | ||
| Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor Dimerization | Q71642294 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| P304 | page(s) | 845-850 | |
| P577 | publication date | 1996-01-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Preferential self-association of basic fibroblast growth factor is stabilized by heparin during receptor dimerization and activation | |
| P478 | volume | 93 |
| Q52209541 | A dimeric ternary complex of FGFR [correction of FGFR1], heparin and FGF-1 leads to an 'electrostatic sandwich' model for heparin binding. |
| Q28582546 | A splice variant of CD44 expressed in the apical ectodermal ridge presents fibroblast growth factors to limb mesenchyme and is required for limb outgrowth |
| Q42834409 | Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells |
| Q38294596 | Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes |
| Q38331346 | Diversity does make a difference: fibroblast growth factor-heparin interactions |
| Q30650531 | Fibroblast growth factors 1 and 2 are distinct in oligomerization in the presence of heparin-like glycosaminoglycans |
| Q34989550 | Heparan sulfate proteoglycan modulation of developmental signaling in Drosophila |
| Q39111023 | Heparin modulates the mitogenic activity of fibroblast growth factor by inducing dimerization of its receptor. a 3D view by using NMR. |
| Q34166436 | Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties |
| Q35044639 | Inhibition by acharan sulphate of angiogenesis in experimental inflammation models |
| Q28587262 | Loss of glypican-3 function causes growth factor-dependent defects in cardiac and coronary vascular development |
| Q52129710 | Membrane heparan sulfate proteoglycan-supported FGF2-FGFR1 signaling: evidence in support of the "cooperative end structures" model. |
| Q37365612 | Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound |
| Q36448331 | Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex |
| Q38335430 | Molecular modeling studies on binding of bFGF to heparin and its receptor FGFR1. |
| Q40957417 | Monomer complexes of basic fibroblast growth factor and heparan sulfate oligosaccharides are the minimal functional unit for cell activation |
| Q61707991 | Morphological study of bone regeneration in the presence of 6-oxychitin |
| Q88212795 | Multivalent conjugates of basic fibroblast growth factor enhance in vitro proliferation and migration of endothelial cells |
| Q40206704 | Nature of Interaction between basic fibroblast growth factor and the antiangiogenic drug 7,7-(carbonyl-bis[imino-N-methyl-4,2-pyrrolecarbonylimino[N-methyl-4,2-pyrrole]-carbonylimino])-bis-(1,3-naphtalene disulfonate). II. Removal of polar interacti |
| Q41657939 | New strategies for chemokine inhibition and modulation: you take the high road and I'll take the low road |
| Q42994167 | Oligomeric self-association of basic fibroblast growth factor in the absence of heparin-like glycosaminoglycans |
| Q38317243 | Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2. |
| Q28273441 | Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2 |
| Q73850106 | Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor |
| Q43568416 | Probing fibroblast growth factor dimerization and role of heparin-like glycosaminoglycans in modulating dimerization and signaling |
| Q33780827 | Putting two and two together: crystal structure of the FGF-receptor complex |
| Q28294538 | Roles of platelet factor 4 in hematopoiesis and angiogenesis |
| Q35023931 | Spherical cancer models in tumor biology |
| Q38294916 | Sucrose octasulfate regulates fibroblast growth factor-2 binding, transport, and activity: potential for regulation of tumor growth |
| Q42826671 | Synthesis and binding mode of heterocyclic analogues of suramin inhibiting the human basic fibroblast growth factor |
| Q33933167 | The biochemical and physiological characteristics of receptors |
| Q57574782 | The emerging role of class II histone deacetylases |
| Q41122012 | The molecular basis of embryonic kidney development |
| Q37876485 | The unconventional secretory machinery of fibroblast growth factor 2. |
| Q36402415 | Using isothermal titration calorimetry to determine thermodynamic parameters of protein-glycosaminoglycan interactions |
Search more.